Drug profile · INN
tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat
GENVOYA
- Patents linked
- 0
- News articles
- 0
Quick answer
tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat (GENVOYA) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
Key facts
INN tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat
Brand GENVOYA
Originator Gilead Sciences Pty Limited
Frequently asked questions
What is tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat?
tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat (GENVOYA) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
What is the brand name for tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat?
GENVOYA is a marketed brand name for tenofovir alafenamide + emtricitabine + elvitegravir + cobicistat. Check FDA Drugs@FDA for the current US label holder and prescribing information.